Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Serina Therapeutics announced its participation in the BTIG Virtual Biotechnology Conference with management holding investor meetings. The company highlighted its proprietary POZ Platform technology designed to optimize drug delivery and its investigational therapy SER-252 for Parkinson's disease. It also noted collaboration with Pfizer to apply i…